HUMAN MONOCLONAL ANTIBODIES TO TNF: NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC SPONDYLITIS
This article contains an example of a successful clinical use of human monoclonal antibodies to tumor necrosis factor (TNF) — adalimumab in patients with severe juvenile idiopathic spondylitis, characterized by resistance to standard antirheumatic treatment and secondary resistance to recombinant (c...
Main Authors: | R.V. Denisova, E.I. Alekseeva |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2011-05-01
|
Series: | Вопросы современной педиатрии |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/629 |
Similar Items
-
HUMAN MONOCLONAL ANTIBODIES TO TNF: NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC SPONDYLITIS
by: R.V. Denisova, et al.
Published: (2011-01-01) -
ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-01-01) -
ABATACEPT — NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-07-01) -
NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010-01-01) -
NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010-01-01)